Roth J, Komminoth P, Heitz P U
Department of Pathology, University of Zürich, Switzerland.
Am J Pathol. 1995 Aug;147(2):489-502.
It has been proposed that the major defect in human insulinomas is a decreased hormone storage capacity resulting in uncontrolled release of proinsulin and insulin. By immunoelectron microscopy with monoclonal antibodies we studied the subcellular distribution of proinsulin and insulin in benign and malignant functioning insulinomas of different histology and compared the findings with various clinical and pathohistological parameters. We found that, in contrast to normal B cells, the proinsulin to insulin conversion in insulinomas occurs already in the trans Golgi apparatus but remains incomplete, resulting in the formation of secretory granules containing both proinsulin and insulin. Thus, in functioning insulinomas, sorting into secretory granules is not a prerequisite for hormone conversion. Furthermore, proinsulin and insulin storage and most probably subsequent secretion occurs through the secretory granules via the regulated pathway. A substantial variability for both proinsulin and insulin immunolabeling in secretory granules was found not only in individual tumor cells but also among the insulinomas studied. This observed variability may account for the lack of correlation between pathohistological, immunohistochemical, and clinical parameters in functioning insulinomas.
有人提出,人类胰岛素瘤的主要缺陷是激素储存能力下降,导致胰岛素原和胰岛素不受控制地释放。通过使用单克隆抗体的免疫电子显微镜技术,我们研究了不同组织学类型的良性和恶性功能性胰岛素瘤中胰岛素原和胰岛素的亚细胞分布,并将研究结果与各种临床和病理组织学参数进行了比较。我们发现,与正常B细胞不同,胰岛素瘤中的胰岛素原向胰岛素的转化已经在反式高尔基体中发生,但仍不完全,导致形成同时含有胰岛素原和胰岛素的分泌颗粒。因此,在功能性胰岛素瘤中,分选到分泌颗粒中不是激素转化的先决条件。此外,胰岛素原和胰岛素的储存以及很可能随后的分泌是通过分泌颗粒经调节途径进行的。不仅在单个肿瘤细胞中,而且在所研究的胰岛素瘤之间,都发现分泌颗粒中胰岛素原和胰岛素免疫标记存在很大差异。这种观察到的差异可能解释了功能性胰岛素瘤中病理组织学、免疫组织化学和临床参数之间缺乏相关性的原因。